The focus on research in protein production by recombinant process has yielded excellent results, with 2 proteins having received Marketing Authorization in India, 1 protein in Phase I clinical studies in Europe aligned to EMEA requirements, another having received DCGI approval to initiate Phase III clinical studies in India and others at various stages of development.
The Biosimilar Research Lab includes
Disclaimer: Products under patents are offered for sale only in those countries where patents have expired.
Website Development by Sharptech Digital Marketing Agency